Sahr Yazdani
Overview
Explore the profile of Sahr Yazdani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi J, Verhaegen M, Yazdani S, Malik R, Harms P, Mangelberger D, et al.
Neoplasia
. 2024 Jun;
55:101019.
PMID: 38943995
No abstract available.
2.
Choi J, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, et al.
Nat Commun
. 2024 Jun;
15(1):5487.
PMID: 38942798
Cancer treatment continues to shift from utilizing traditional therapies to targeted ones, such as protein kinase inhibitors and immunotherapy. Mobilizing dendritic cells (DC) and other myeloid cells with antigen presenting...
3.
Choi J, Verhaegen M, Yazdani S, Malik R, Harms P, Mangelberger D, et al.
Neoplasia
. 2024 Apr;
51:100995.
PMID: 38574506
No abstract available.
4.
Choi J, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, et al.
bioRxiv
. 2024 Mar;
PMID: 38464258
The modern armamentarium for cancer treatment includes immunotherapy and targeted therapy, such as protein kinase inhibitors. However, the mechanisms that allow cancer-targeting drugs to effectively mobilize dendritic cells (DCs) and...
5.
Guzman H, Yazdani S, Harmon J, Chapman K, Vitola B, Pyle L, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1268135.
PMID: 38027095
Timely diagnosis of persistent neonatal hypoglycemia is critical to prevent neurological sequelae, but diagnosis is complicated by the heterogenicity of the causes. We discuss two cases at separate institutions in...
6.
Lerman B, Li Y, Carlowicz C, Granger M, Cash T, Sadanand A, et al.
J Clin Oncol
. 2022 Oct;
41(3):508-516.
PMID: 36206505
Purpose: Although chemoimmunotherapy is widely used for treatment of children with relapsed high-risk neuroblastoma (HRNB), little is known about timing, duration, and evolution of response after irinotecan/temozolomide/dinutuximab/granulocyte-macrophage colony-stimulating factor (I/T/DIN/GM-CSF)...
7.
Yazdani S, Bloomberg Z, Klauber R, Meresh E
Eat Weight Disord
. 2022 May;
27(7):2943-2945.
PMID: 35608814
The COVID-19 pandemic has significantly increased the prevalence of psychiatric disorders within pediatric populations. However, only a limited number of studies have sought to understand the correlation between the pandemic...
8.
Yazdani S, Capuano A, Ghaziuddin M, Colombi C
Brain Sci
. 2020 Feb;
10(2).
PMID: 32069875
This literature review evaluated early behavioral intervention studies of Autism Spectrum disorder (ASD) based on their participant exclusion criteria. The studies included were found through searching PsycINFO and PubMed databases,...
9.
Choi J, Verhaegen M, Yazdani S, Malik R, Harms P, Mangelberger D, et al.
Neoplasia
. 2019 Feb;
21(3):322-330.
PMID: 30797188
Studies on the efficacy of small molecule inhibitors in Merkel cell carcinoma (MCC) have been limited and largely inconclusive. In this study, we investigated the therapeutic potential of a potent...
10.
Zhang Y, Pitchiaya S, Cieslik M, Niknafs Y, Tien J, Hosono Y, et al.
Nat Genet
. 2018 May;
50(6):814-824.
PMID: 29808028
The androgen receptor (AR) plays a critical role in the development of the normal prostate as well as prostate cancer. Using an integrative transcriptomic analysis of prostate cancer cell lines...